Skip to content
Screener

Accounts Payable at other companies

Polaryx Therapeutics, Inc. logo
Polaryx Therapeutics, Inc.PLYX
$850K+5,100%
Veradermics logo
VeradermicsMANE
$1.07M+256%
GPA
General Purpose Acquisition Corp.GPAC
$8.46M-29.1%
Schering-Plough logo
Schering-PloughSGP
$3.51M+1,045%
Dollar General logo
Dollar GeneralDG
$4.34B+13.2%
Target logo
TargetTGT
$12.19B+3.1%

Other financials

Income statement

See full
Operating income-$26.1M-62.4%
Net income-$24.2M-97.8%
EPS (diluted)-$0.80+93.8%

Balance sheet

See full
Cash & equivalents$237.4M
Total debt$1.0M
Total equity$454.3M+421%
Total assets$467.8M

Cash flow

See full
Operating cash flow-$22.6M-47.6%
CapEx$23.0K
Free cash flow-$22.7M-47.8%

Valuation

See full
Market cap$2.32B+107%
Enterprise value$2.08B

Returns & leverage

See full
Return on equity-45.7%
Debt / equity
Current ratio35.8×

Where this comes from

Reported directly by Hemab Therapeutics Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The source filing: Hemab Therapeutics Holdings, Inc.’s 10-Q, filed August 11, 2026. Open the filing →

Filed
Aug 11, 2026, 4:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-344533

FAQ

What is Hemab Therapeutics Holdings, Inc.'s accounts payable?
Hemab Therapeutics Holdings, Inc. (COAG) reported accounts payable of $6.23M in Q2 2026.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.

Ask your AI about Hemab Therapeutics Holdings, Inc.'s accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude